Issue navigation
Volume 36, Issue 1, January 2021
EDITORIALS
Virtual reality: the dawn of a new ERA
Nephrology Dialysis Transplantation, Volume 36, Issue 1, January 2021, Pages 1–4, https://doi.org/10.1093/ndt/gfaa255
Every obstruction does not need a stent: an important lesson from the ISCHEMIA-CKD trial for kidney-transplant surgeons
Nephrology Dialysis Transplantation, Volume 36, Issue 1, January 2021, Pages 4–8, https://doi.org/10.1093/ndt/gfaa157
COVID-19 and policy changes for kidney disease: the need for a ‘decade of the kidney’
Nephrology Dialysis Transplantation, Volume 36, Issue 1, January 2021, Pages 8–11, https://doi.org/10.1093/ndt/gfaa339
Rituximab in fibrillary glomerulonephritis: fumble or forward progress?
Nephrology Dialysis Transplantation, Volume 36, Issue 1, January 2021, Pages 11–13, https://doi.org/10.1093/ndt/gfaa186
Personalizing potassium management in patients on haemodialysis
Nephrology Dialysis Transplantation, Volume 36, Issue 1, January 2021, Pages 13–18, https://doi.org/10.1093/ndt/gfaa213
REVIEWS
Imaging the kidney: from light to super-resolution microscopy
Nephrology Dialysis Transplantation, Volume 36, Issue 1, January 2021, Pages 19–28, https://doi.org/10.1093/ndt/gfz136
One concept does not fit all: the immune system in different forms of acute kidney injury
Nephrology Dialysis Transplantation, Volume 36, Issue 1, January 2021, Pages 29–38, https://doi.org/10.1093/ndt/gfaa056
NDT DIGEST
Cystatin C to predict renal disease and cardiovascular risk
Nephrology Dialysis Transplantation, Volume 36, Issue 1, January 2021, Pages 39–41, https://doi.org/10.1093/ndt/gfaa152
SPECIAL REPORT
European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4–G5D
Nephrology Dialysis Transplantation, Volume 36, Issue 1, January 2021, Pages 42–59, https://doi.org/10.1093/ndt/gfaa192
ORIGINAL ARTICLES
Basic Research
Differential role of nicotinamide adenine dinucleotide deficiency in acute and chronic kidney disease
Nephrology Dialysis Transplantation, Volume 36, Issue 1, January 2021, Pages 60–68, https://doi.org/10.1093/ndt/gfaa124
Evidence of an intestinal phosphate transporter alternative to type IIb sodium-dependent phosphate transporter in rats with chronic kidney disease
Nephrology Dialysis Transplantation, Volume 36, Issue 1, January 2021, Pages 68–75, https://doi.org/10.1093/ndt/gfaa156
Aberrant mucosal immunoreaction to tonsillar microbiota in immunoglobulin A nephropathy
Nephrology Dialysis Transplantation, Volume 36, Issue 1, January 2021, Pages 75–86, https://doi.org/10.1093/ndt/gfaa223
Clinical Research
Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA
Nephrology Dialysis Transplantation, Volume 36, Issue 1, January 2021, Pages 87–94, https://doi.org/10.1093/ndt/gfaa314
Muscle mass and plasma myostatin after exercise training: a substudy of Renal Exercise (RENEXC)—a randomized controlled trial
Nephrology Dialysis Transplantation, Volume 36, Issue 1, January 2021, Pages 95–103, https://doi.org/10.1093/ndt/gfz210
Treatment of fibrillary glomerulonephritis with rituximab: a 12-month pilot study
Nephrology Dialysis Transplantation, Volume 36, Issue 1, January 2021, Pages 104–110, https://doi.org/10.1093/ndt/gfaa065
Safety and efficacy of iron isomaltoside 1000/ferric derisomaltose versus iron sucrose in patients with chronic kidney disease: the FERWON-NEPHRO randomized, open-label, comparative trial
Nephrology Dialysis Transplantation, Volume 36, Issue 1, January 2021, Pages 111–120, https://doi.org/10.1093/ndt/gfaa011
Fibroblast growth factor 23 and new-onset chronic kidney disease in the general population: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study
Nephrology Dialysis Transplantation, Volume 36, Issue 1, January 2021, Pages 121–128, https://doi.org/10.1093/ndt/gfz266
Prevalence, correlates and outcomes of absolute and functional iron deficiency anemia in nondialysis-dependent chronic kidney disease
Nephrology Dialysis Transplantation, Volume 36, Issue 1, January 2021, Pages 129–136, https://doi.org/10.1093/ndt/gfz192
Long-term safety and efficacy of sodium zirconium cyclosilicate for hyperkalaemia in patients with mild/moderate versus severe/end-stage chronic kidney disease: comparative results from an open-label, Phase 3 study
Nephrology Dialysis Transplantation, Volume 36, Issue 1, January 2021, Pages 137–150, https://doi.org/10.1093/ndt/gfz285
Dialysis
Prescription patterns of dialysate potassium and potassium binders and survival on haemodialysis—the French Renal Epidemiology and Information Network registry
Nephrology Dialysis Transplantation, Volume 36, Issue 1, January 2021, Pages 151–159, https://doi.org/10.1093/ndt/gfaa077
The risk of medically uncontrolled secondary hyperparathyroidism depends on parathyroid hormone levels at haemodialysis initiation
Nephrology Dialysis Transplantation, Volume 36, Issue 1, January 2021, Pages 160–169, https://doi.org/10.1093/ndt/gfaa195
Bleeding risk of haemodialysis and peritoneal dialysis patients
Nephrology Dialysis Transplantation, Volume 36, Issue 1, January 2021, Pages 170–175, https://doi.org/10.1093/ndt/gfaa216
Transplantation
Higher mortality risk among kidney transplant recipients than among estimated glomerular filtration rate–matched patients with CKD—preliminary results
Nephrology Dialysis Transplantation, Volume 36, Issue 1, January 2021, Pages 176–184, https://doi.org/10.1093/ndt/gfaa026
Acute kidney injury in renal transplant recipients undergoing cardiac surgery
Nephrology Dialysis Transplantation, Volume 36, Issue 1, January 2021, Pages 185–196, https://doi.org/10.1093/ndt/gfaa063
